miR ‐34a is upregulated in AIP ‐ mutated somatotropinomas and promotes octreotide resistance
出版年份 2020 全文链接
标题
miR
‐34a is upregulated in
AIP
‐
mutated somatotropinomas and promotes octreotide resistance
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-08-29
DOI
10.1002/ijc.33268
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CircOMA1 mediated miR-145-5p suppresses tumor growth of nonfunctioning pituitary adenomas by targeting TPT1
- (2019) Qiu Du et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors
- (2019) Antonio C. Fuentes-Fayos et al. Minerva Endocrinologica
- AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
- (2019) Adrian F Daly et al. Endocrine Connections
- Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother
- (2019) Brittany K Wise-Oringer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Interaction of AIP with protein kinase A (cAMP-dependent protein kinase)
- (2018) Marie Helene Schernthaner-Reiter et al. HUMAN MOLECULAR GENETICS
- Overexpression of microRNA-34a Attenuates Proliferation and Induces Apoptosis in Pituitary Adenoma Cells via SOX7
- (2018) Zijiang Yang et al. Molecular Therapy-Oncolytics
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- The Over-Expression of miR-34a Fails to Block DoHH2 Lymphoma Cell Proliferation by Reducing p53 via c-MYC Down-Regulation
- (2018) Milena Rizzo et al. Nucleic Acid Therapeutics
- Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1
- (2018) M. Jian et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
- (2017) Felipe F. Casanueva et al. Pituitary
- MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro
- (2017) Kai Zhou et al. OncoTargets and Therapy
- miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA
- (2016) Peng Wang et al. CELL PROLIFERATION
- cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors
- (2016) Graeme B Bolger et al. ENDOCRINE-RELATED CANCER
- Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomas
- (2016) Elina Ritvonen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With MissenseAIPMutations
- (2016) Laura C. Hernández-Ramírez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The surgical treatment of acromegaly
- (2016) Michael Buchfelder et al. Pituitary
- Effect and mechanism of miR-34a on proliferation, apoptosis and invasion of laryngeal carcinoma cells
- (2016) Ju-Xiang Wang et al. Asian Pacific Journal of Tropical Medicine
- MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR
- (2016) Claudia J. Krause et al. Oncotarget
- Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma
- (2016) ChuanTing Yu et al. MEDICAL SCIENCE MONITOR
- Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development
- (2015) N. Dimitrova et al. Cancer Discovery
- Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
- (2015) Judit Dénes et al. PLoS One
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms
- (2014) Maria Braoudaki et al. Journal of Hematology & Oncology
- Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
- (2014) Giampaolo Trivellin et al. NEW ENGLAND JOURNAL OF MEDICINE
- AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling
- (2014) I Tuominen et al. ONCOGENE
- Mutation Analysis of Inhibitory Guanine Nucleotide Binding Protein Alpha (GNAI) Loci in Young and Familial Pituitary Adenomas
- (2014) Hande Demir et al. PLoS One
- Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
- (2013) Albert Beckers et al. ENDOCRINE REVIEWS
- Aip regulates cAMP signalling and GH secretion in GH3 cells
- (2013) R Formosa et al. ENDOCRINE-RELATED CANCER
- A proteomic approach of pediatric astrocytomas: MiRNAs and network insight
- (2013) Ruth Ruiz Esparza-Garrido et al. Journal of Proteomics
- Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines
- (2013) Federico Tagliati et al. PLoS One
- MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
- (2012) Giampaolo Trivellin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Myc overexpression brings out unexpected antiapoptotic effects of miR-34a
- (2011) E Sotillo et al. ONCOGENE
- Differential expression of microRNAs in GH-secreting pituitary adenomas
- (2010) Zhi-Gang Mao et al. Diagnostic Pathology
- Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families
- (2010) Susana Igreja et al. HUMAN MUTATION
- A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization
- (2010) Sara Molatore et al. HUMAN MUTATION
- Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study
- (2010) Adrian F. Daly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53
- (2010) Leandro Kasuki Jomori de Pinho et al. NEUROENDOCRINOLOGY
- MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas
- (2010) Henriett Butz et al. Pituitary
- Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma
- (2010) S. Molatore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTNNB1 Gene Mutations, Pituitary Transcription Factors, and MicroRNA Expression Involvement in the Pathogenesis of Adamantinomatous Craniopharyngiomas
- (2010) Marina Lanciotti Campanini et al. Hormones & Cancer
- Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
- (2009) Marie-Lise Jaffrain-Rea et al. ENDOCRINE-RELATED CANCER
- Signalling Pathway Alterations in Pituitary Adenomas: Involvement of Gsα, cAMP and Mitogen-Activated Protein Kinases
- (2009) M. Pertuit et al. JOURNAL OF NEUROENDOCRINOLOGY
- MicroRNA profiling in human medulloblastoma
- (2008) Elisabetta Ferretti et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors
- (2008) Fernando Colbari Amaral et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started